Bettencourt P Azevedo A Pimenta J Frioes F Ferreira S Ferreira A.

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

Circulation. 110: 2168-2174Doust JA Pietrzak E Dobson A Glasziou P.

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.

BMJ. 330: 625van Kimmenade RR Januzzi Jr, JL Ellinor PT Sharma UC Bakker JA Low AF Martinez A Crijns HJ MacRae CA Menheere PP Pinto YM

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.

J Am Coll Cardiol. 48: 1217-1224Yancy CW Jessup M Bozkurt B Butler J Casey Jr., DE Drazner MH Fonarow GC Geraci SA Horwich T Januzzi JL Johnson MR Kasper EK Levy WC Masoudi FA McBride PE McMurray JJ Mitchell JE Peterson PN Riegel B Sam F Stevenson LW Tang WH Tsai EJ Wilkoff BL

American College of Cardiology F and American Heart Association Task Force on Practice G. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

J Am Coll Cardiol. 62: e147-e239Troughton RW Frampton CM Brunner-La Rocca HP Pfisterer M Eurlings LW Erntell H Persson H O'Connor CM Moertl D Karlstrom P Dahlstrom U Gaggin HK Januzzi JL Berger R Richards AM Pinto YM Nicholls MG

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis.

Eur Heart J. 35: 1559-1567Januzzi Jr, JL Filippatos G Nieminen M Gheorghiade M

Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section.

Eur Heart J. 33: 2265-2271Gravning J Askevold ET Nymo SH Ueland T Wikstrand J McMurray JJ Aukrust P Gullestad L Kjekshus J Group CS.

Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.

Circ Heart Fail. 7: 96-103Aimo A Januzzi Jr., JL Vergaro G Ripoli A Latini R Masson S Magnoli M Anand IS Cohn JN Tavazzi L Tognoni G Gravning J Ueland T Nymo SH Brunner-La Rocca HP Bayes-Genis A Lupon J de Boer RA Yoshihisa A Takeishi Y Egstrup M Gustafsson I Gaggin HK Eggers KM Huber K Tentzeris I Tang WHW Grodin J Passino C Emdin M

Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.

Circulation. 137: 286-297Weinberg EO Shimpo M Hurwitz S Tominaga S Rouleau JL Lee RT.

Identification of serum soluble ST2 receptor as a novel heart failure biomarker.

Circulation. 107: 721-726Broch K Ueland T Nymo SH Kjekshus J Hulthe J Muntendam P McMurray JJ Wikstrand J Cleland JG Aukrust P Gullestad L

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology.

Eur J Heart Fail. 14: 268-277van Vark LC Lesman-Leegte I Baart SJ Postmus D Pinto YM Orsel JG Westenbrink BD Brunner-la Rocca HP van Miltenburg AJM Boersma E Hillege HL

Akkerhuis KM and Investigators T. Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.

J Am Coll Cardiol. 70: 2378-2388Emdin M Aimo A Vergaro G Bayes-Genis A Lupon J Latini R Meessen J Anand IS Cohn JN Gravning J Gullestad L Broch K Ueland T Nymo SH Brunner-La Rocca HP de Boer RA Gaggin HK Ripoli A Passino C Januzzi Jr., JL

sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.

J Am Coll Cardiol. 72: 2309-2320O'Meara E Prescott MF Claggett B Rouleau JL Chiang LM Solomon SD Packer M McMurray JJV Zile MR.

Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure).

Circ Heart Fail. 11e004446Aimo A Vergaro G Ripoli A Bayes-Genis A Pascual Figal DA de Boer RA Lassus J Mebazaa A Gayat E Breidthardt T Sabti Z Mueller C Brunner-La Rocca HP Tang WH Grodin JL Zhang Y Bettencourt P Maisel AS Passino C Januzzi JL Emdin M

Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure.

JACC Heart Fail. 5: 287-296Kotooka N Inoue T Aoki S Anan M Komoda H Node K.

Prognostic value of pentraxin 3 in patients with chronic heart failure.

Int J Cardiol. 130: 19-22Suzuki S Takeishi Y Niizeki T Koyama Y Kitahara T Sasaki T Sagara M Kubota I.

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.

Am Heart J. 155: 75-81Latini R Gullestad L Masson S Nymo SH Ueland T Cuccovillo I Vardal M Bottazzi B Mantovani A Lucci D Masuda N Sudo Y Wikstrand J Tognoni G Aukrust P Tavazzi L

Investigators of the Controlled Rosuvastatin Multinational Trial in Heart F and trials GI-HF. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.

Eur J Heart Fail. 14: 992-999Matsubara J Sugiyama S Nozaki T Akiyama E Matsuzawa Y Kurokawa H Maeda H Fujisue K Sugamura K Yamamoto E Matsui K Jinnouchi H Ogawa H.

Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.

J Am Heart Assoc. 3Matsubara J Sugiyama S Nozaki T Sugamura K Konishi M Ohba K Matsuzawa Y Akiyama E Yamamoto E Sakamoto K Nagayoshi Y Kaikita K Sumida H Kim-Mitsuyama S Ogawa H.

Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction.

J Am Coll Cardiol. 57: 861-869Lok DJ Van Der Meer P de la Porte PW Lipsic E Van Wijngaarden J HL Hillege van Veldhuisen DJ.

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.

Clin Res Cardiol. 99: 323-328Shah RV Chen-Tournoux AA Picard MH van Kimmenade RR Januzzi JL.

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure.

Eur J Heart Fail. 12: 826-832Ho JE Liu C Lyass A Courchesne P Pencina MJ Vasan RS Larson MG Levy D

Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.

J Am Coll Cardiol. 60: 1249-1256Sharma UC Pokharel S van Brakel TJ van Berlo JH Cleutjens JP Schroen B Andre S Crijns HJ Gabius HJ Maessen J Pinto YM.

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

Circulation. 110: 3121-3128Bottazzi B Bastone A Doni A Garlanda C Valentino S Deban L Maina V Cotena A Moalli F Vago L Salustri A Romani L Mantovani A.

The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility.

J Leukoc Biol. 79: 909-912Sanada S Hakuno D Higgins LJ Schreiter ER McKenzie AN Lee RT.

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.

J Clin Invest. 117: 1538-1549Ho KK Anderson KM Kannel WB Grossman W Levy D

Survival after the onset of congestive heart failure in Framingham Heart Study subjects.

Circulation. 88: 107-115Hicks KA Tcheng JE Bozkurt B Chaitman BR Cutlip DE Farb A Fonarow GC Jacobs JP Jaff MR Lichtman JH Limacher MC Mahaffey KW Mehran R Nissen SE Smith EE Targum SL.

2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).

J Am Coll Cardiol. 66: 403-469Lang RM Badano LP Mor-Avi V Afilalo J Armstrong A Ernande L Flachskampf FA Foster E Goldstein SA Kuznetsova T Lancellotti P Muraru D Picard MH Rietzschel ER Rudski L Spencer KT Tsang W Voigt JU.

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 28 ()

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O'Gara PT, Rigolin VH, Sundt TM, 3rd and Thompson A. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159-e1195.

Bouillanne O Morineau G Dupont C Coulombel I Vincent JP Nicolis I Benazeth S Cynober L Aussel C.

Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients.

Am J Clin Nutr. 82: 777-783Pocock SJ Ariti CA McMurray JJ Maggioni A Kober L Squire IB Swedberg K Dobson J Poppe KK Whalley GA

Doughty RN and Meta-Analysis Global Group in Chronic Heart F. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.

Eur Heart J. 34: 1404-1413Sugano A Seo Y Ishizu T Sai S Yamamoto M Hamada-Harimura Y Machino-Ohtsuka T Obara K Nishi I Aonuma K Nogami A.

Soluble ST2 and brain natriuretic peptide predict different mode of death in patients with heart failure and preserved ejection fraction.

Journal of cardiology. 73: 326-332Agra Bermejo RM González Ferreiro R Varela Román A Gómez Otero I Kreidieh O Conde Sabarís P Rodríguez-Mañero M Moure González M Seoane Blanco A Virgós Lamela A García Castelo A González Juanatey JR

Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure.

Int J Cardiol. 230: 108-114Iwakami N Nagai T Furukawa TA Sugano Y Honda S Okada A Asaumi Y Aiba T Noguchi T Kusano K Ogawa H Yasuda S Anzai T

Prognostic value of malnutrition assessed by Controlling Nutritional Status score for long-term mortality in patients with acute heart failure.

Int J Cardiol. 230: 529-536Nishi I Seo Y Hamada-Harimura Y Yamamoto M Ishizu T Sugano A Sato K Sai S Obara K Suzuki S Koike A Aonuma K Ieda M Cardiovascular Ibaraki

Assessment Study-Heart Failure I. Geriatric nutritional risk index predicts all-cause deaths in heart failure with preserved ejection fraction.

ESC heart failure. 6: 396-405Daniels LB Clopton P Iqbal N Tran K Maisel AS

Association of ST2 levels with cardiac structure and function and mortality in outpatients.

Am Heart J. 160: 721-728Colombo PC Onat D Harxhi A Demmer RT Hayashi Y Jelic S LeJemtel TH Bucciarelli L Kebschull M Papapanou P Uriel N Schmidt AM Sabbah HN UP Jorde

Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation.

Eur Heart J. 35: 448-454Demissei BG Cotter G Prescott MF Felker GM Filippatos G Greenberg BH Pang PS Ponikowski P Severin TM Wang Y Qian M Teerlink JR Metra M Davison BA Voors AA.

A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.

Eur J Heart Fail. 19: 1001-1010